Gosogliptin

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGosogliptin
Drug Alias NameDPP IV inhibitor戈格列汀盐酸盐gosogliptinum盐酸戈索格列汀gosogliptine +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2Renal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden +[10] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSatrx LlcPfizer Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Renal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksKEGG